Key Highlights
- The Department of Commerce and Rigetti have entered into a letter of intent for CHIPS Act funding of up to $100 million across a three-year period.
- Shares of RGTI climbed nearly 20% during Friday trading, ending the session at $26.42 amid a quantum sector-wide rally.
- The proposed funding will address critical technical obstacles in superconducting quantum systems, particularly chip miniaturization and enhanced cryostat design.
- Terms include a possible government equity position, raising potential dilution concerns for current shareholders upon finalization.
- Wall Street maintains a Moderate Buy rating on RGTI with average price projections hovering around $29–$30, suggesting limited near-term upside.
Shares of Rigetti Computing (RGTI) experienced a substantial rally on Friday, climbing nearly 20% following news that the company entered into a letter of intent with the U.S. Department of Commerce. The agreement outlines potential funding of up to $100 million under the CHIPS Act initiative. Trading concluded with RGTI at $26.42.
This funding represents a portion of the government’s comprehensive $2.013 billion commitment under the CHIPS and Science Act, distributed among nine companies. The majority—seven recipients—are quantum computing specialists, including D-Wave, PsiQuantum, Quantinuum, and Infleqtion. The remaining two beneficiaries are IBM and GlobalFoundries.
Rigetti’s allocated portion—potentially reaching $100 million distributed over three years—targets the advancement and commercialization of cutting-edge superconducting quantum technologies. Priority areas encompass compact readout electronics and optimized cryogenic system architecture.
Chief Executive Subodh Kulkarni characterized the commitment as validation from federal authorities. “This capital injection enables us to address critical scaling challenges with greater urgency and advances our timeline toward commercially viable quantum computing,” Kulkarni stated.
A noteworthy provision merits attention: the agreement incorporates a potential equity component for the federal government proportional to the funding disbursed. Unlike conventional research grants, this structure provides Washington with a financial stake in Rigetti’s technological advancement. Current shareholders should note the dilution risk if the arrangement proceeds to completion.
Rigetti’s Technological Approach
Rigetti’s foundation rests on superconducting qubit technology—the identical fundamental approach employed by IBM and Alphabet, yet with distinctive implementation. The company leverages a chiplet-based design philosophy, integrating multiple smaller quantum processors into unified systems.
The company’s 108-qubit Cepheus processor exemplifies this methodology, constructed from twelve individual 9-qubit chiplets. This strategy aims to simplify scalability challenges by circumventing certain manufacturing obstacles inherent in monolithic large-chip fabrication. Gate operation speeds range from 50 to 70 nanoseconds, offering competitive performance versus alternative quantum methodologies.
This strategic positioning distinguishes Rigetti from competitors like IonQ, which utilizes trapped-ion quantum technology, and IBM, which commands significantly greater capital resources. Rigetti’s value proposition emphasizes vertical integration: comprehensive stack control, high-speed superconducting architectures, and deployment flexibility encompassing both cloud-based and dedicated on-premises installations—particularly valuable for government laboratories requiring secure, air-gapped quantum access.
Wall Street Perspective and Financial Performance
Analyst sentiment remains cautiously favorable. Among 13 analysts tracking the security, eight recommend buying, four advise holding, and one suggests selling. Consensus 12-month price projections cluster around $29–$30, indicating approximately 13% appreciation potential from Friday’s closing price.
Rigetti’s latest quarterly disclosure exceeded market expectations. The company posted earnings per share of -$0.04, outperforming the -$0.05 consensus estimate. Revenue reached $4.4 million, representing 198.9% year-over-year growth and surpassing the $4.09 million projection.
The stock benefited additionally from broader quantum sector momentum triggered by the government’s funding announcement. Competitor IonQ advanced 8% while D-Wave gained 14% during the same trading session. RGTI has appreciated approximately 48% over the trailing seven-day period.
Benchmark reiterated its buy recommendation while adjusting its price objective downward from $35 to $25. Rosenblatt maintains a $40 target. The stock’s 52-week trading range spans $10.30 to $58.15, with the 50-day moving average positioned at $16.82.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
